Supplementary Data from Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib
Work
Year: 2024
Type: preprint
Abstract: <p>Supplementary Data</p>
Cites:
Cited by:
Related to: 10
Citation percentile (by year/subfield):
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green